CYTOKINETICS INC (CYTK)
US23282W6057 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 99.70M | 65.60M | 112.70M | 83.00M | 36.40M | |||
| Marketable Securities | 439.50M | 717.00M | 359.00M | 381.10M | 188.70M | |||
| Receivables | 2.50M | 100.00K | 51.80M | 4.40M | 5.20M | |||
| Other Current Assets | 19.70M | 12.50M | 12.20M | 5.70M | 3.50M | |||
| Total Current Assets | 561.40M | 795.20M | 535.70M | 474.20M | 233.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 155.50M | 163.20M | 146.40M | 22.60M | 13.40M | |||
| Investments And Advances | 15.50M | 46.70M | 152.10M | 37.00M | 42.70M | |||
| Other Non-Current Assets | 8.20M | 9.70M | 7.20M | N/A | N/A | |||
| Total Non-Current Assets | 179.20M | 219.60M | 305.60M | 59.60M | 56.00M | |||
| TOTAL ASSETS | 740.60M | 1.01B | 841.30M | 533.80M | 289.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 1.00M | 500.00K | N/A | 0.00 | |||
| Accrued Expenses | 50.20M | 56.90M | 49.20M | 22.10M | 16.70M | |||
| Accounts Payable | 13.80M | 25.60M | 21.10M | 8.10M | 8.20M | |||
| Other Current Liabilities | 13.70M | 1.10M | 1.00M | 1.00M | 1.10M | |||
| Total Current Liabilities | 77.70M | 84.60M | 71.90M | 31.20M | 26.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 609.00M | 610.60M | 143.60M | 135.70M | 129.30M | |||
| Other Non-Current Liabilities | 492.70M | 427.40M | 382.00M | 253.50M | 145.50M | |||
| Total Non-Current Liabilities | 1.10B | 1.04B | 525.60M | 389.20M | 274.80M | |||
| TOTAL LIABILITIES | 1.18B | 1.12B | 597.50M | 420.40M | 300.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.98B | -1.59B | -1.21B | -992.30M | -865.00M | |||
| Additional Paid In Capital | 1.54B | 1.48B | 1.45B | 1.11B | 853.30M | |||
| Common Shares | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -900.00K | -3.60M | -900.00K | 100.00K | 700.00K | |||
| Shares Outstanding | 96.30M | 94.80M | 84.80M | 71.00M | 59.20M | |||
| Tangible Book Value per Share | -4.56 | -1.14 | 2.88 | 1.60 | -0.18 | |||
| Total Shareholders' Equity | -438.80M | -107.90M | 243.90M | 113.40M | -10.90M | |||
| TOTAL LIABILITIES AND EQUITY | 740.60M | 1.01B | 841.30M | 533.80M | 289.80M | |||
| Statistics | ||||||||
| Debt/Equity | -1.39 | -5.66 | 0.59 | 1.20 | -11.86 | |||
| Current Ratio | 7.23 | 9.40 | 7.45 | 15.20 | 8.99 | |||
| Return On Assets (ROA) | -71.12% | -38.33% | -25.59% | -23.85% | -41.99% | |||
| Return On Equity (ROE) | N/A | N/A | -88.27% | -112.26% | N/A | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD